Several drugmakers whose sales boomed on COVID-19 vaccines and related products in 2021 and 2022 have now been embroiled in a hangover…
McAlinden Research PartnersOctober 18, 2023
Summary: Ongoing shortages of popular obesity-fighting drugs from Novo Nordisk represent the surging popularity of medication-based intervention as treatment. Though…
McAlinden Research PartnersJuly 25, 2023
Pfizer's acquisition of Seagen, which is the largest biopharma deal since 2019, comes as products received in previous deals begin…
McAlinden Research PartnersMarch 14, 2023
Three pharma giants are in the running to purchase Horizon Therapeutics in what will likely be a larger deal than…
McAlinden Research PartnersDecember 1, 2022
